Applied Pharma Research S.A. (APR) has widened the global partnership network of the baby healthcare brand, Halykoo, thanks to an agreement with Amicus S.A., a leading distributor of pharmaceutical and OTC products in the former Yugoslavia.
Halykoo is a new pediatric brand, conceived and developed by APR, which aims to transform the moment of child healthcare in a peaceful, simple and safe time of relation between mother and kid, getting parents’ confidence and smiling babies.
Halykoo products are the perfect combination of responsible, Swiss, high-quality research combined with an extensive understanding of child and caregivers needs: as a result, each Halykoo product provides the right formulation and the right delivery system for the right age.
This partnership will allow Amicus to strengthen its position in the pharmacy channel, due to Halykoo’s unique selling proposition, as confirmed by the COO P. Lukic, who stressed also how the Balkan pediatric healthcare market is expected to keep on growing, with the self-care sector exceeding 20% of the pharma market.
“Distinctive brand, unique communication strategy and socially-acceptable pricing” stated Amicus Serbia Director of Consumer Medicines, S. Petrovic, confident that Halykoo product will be a leading brand in the pharmacy channel.
APR is pleased of this partnership with Amicus and expects that Halykoo high quality and innovative products will be soon available in many other countries all over the world.
For more info about Halykoo please visit: www.halykoo.com.